Creso Pharma (ASX:CPH) subsidiary Mernova managing director Jack Yu and vice president Isaac Allen joined Steve Darling from Proactive to discuss the granting of their sales license from Health Canada and what it allows them to do.
Isaac Allen tells Proactive they are gearing up sales efforts and see a number of avenues to increase sales growth.
Price: 0.034 AUD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Creso Pharma Ltd named herein, including the promotion by the Company of Creso Pharma Ltd in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HERE
Australian Vanadium Ltd (ASX:AVL) (OTCMKTS:ATVVF) managing director Vincent Algar speaks to Proactive about recent pilot test-work conducted at the Australian Vanadium Project, which delivered leach extraction of up to 94.7%. The pilot-scale roast and leach testing has confirmed the...
Telecoms & Networks
Mobilicom CEO hails Space Florida drone deal and discusses new...
Mining
K2fly's Nic Pollock discusses new deal with Decipher for tailings...
Mining
